GPCR stock opened at $29.97 on Monday. The business has a 50-day moving average price of $29.65 and a 200 day moving average price of $35.20. Structure Therapeutics has a 1-year low of $23.50 and ...

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst JPMorgan highlights valuation resets for Viking and Structure Therapeutics ...

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has received an average rating of “Buy” from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports.

1 Day GPCR -1.40% DJIA 0.38% S&P Mid Cap 400 1.15% Health Care/Life Sciences 0.19% ...

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

So, the natural question for Structure Therapeutics (NASDAQ:GPCR) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn ...

Fintel reports that on January 8, 2025, Stifel initiated coverage of Structure Therapeutics Inc. - Depositary Receipt () (NasdaqGM:GPCR) with a Buy recommendation. Analyst Price Forecast Suggests ...

In trading on Monday, shares of Structure Therapeutics Inc (Symbol: GPCR) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $23.50 per share.